 | Staurosporine | IC50 | 15.0 [1] |
 | Rosmarinic acid | IC50 | 17000.0 [1] |
| Rosmarinic acid | Ki | 7500.0 [1], 10200.0 [2] |
 | Doramapimod | IC50 | 1000.0 [1], 20000.0 [2], 24000.0 [3], 30000.0 [4] |
 | 4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline | IC50 | 1.0 [1], 42.0 [2], 420.0 [3], 300000.0 [4] |
 | N-(4-Phenylamino-Quinazolin-6-Yl)-Acrylamide | IC50 | 5.0 [1], 6.0 [2], 1100.0 [3], 3700.0 [4] |
 | N-(4-(4-Tert-Butylphenylamino)quinazolin-6-yl)acrylamide | IC50 | 24.0 [1], 900.0 [2], 8400.0 [3], 300000.0 [4] |
 | N-(4-(4-Bromophenylamino)quinazolin-6-yl)acrylamide | IC50 | 19.0 [1], 34.0 [2], 4650.0 [3], 300000.0 [4] |
 | N-[4-(4-Phenylanilino)quinazolin-6-yl]prop-2-enamide | IC50 | 107.0 [1], 760.0 [2], 9700.0 [3], 300000.0 [4] |
 | N-(4-(4-Isopropylphenylamino)quinazolin-6-yl)acrylamide | IC50 | 32.0 [1], 340.0 [2], 2200.0 [3], 300000.0 [4] |
 | N-(4-(Naphthalen-2-ylamino)quinazolin-6-yl)acrylamide | IC50 | 3.0 [1], 32.0 [2], 1800.0 [3], 18100.0 [4] |
 | N-(4-(Naphthalen-1-ylamino)quinazolin-6-yl)acrylamide | IC50 | 30.0 [1], 670.0 [2], 2100.0 [3], 16300.0 [4] |
 | N-(4-((Naphthalen-1-yl)methylamino)quinazolin-6-yl)acrylamide | IC50 | 150.0 [1], 1500.0 [2], 1700.0 [3], 32000.0 [4] |
 | N-(4-(Phenethylamino)quinazolin-6-yl)acrylamide | IC50 | 88.0 [1], 1400.0 [2], 3800.0 [3], 40000.0 [4] |
 | N-(4-(4-Tert-Butylphenylamino)quinazolin-6-yl)propionamide | IC50 | 540.0 [1], 1500.0 [2], 300000.0 [3] |
 | Bosutinib | IC50 | 1.8 [1], 410.0 [2] |
 | 7-[cis-4-(4-Methylpiperazin-1-Yl)cyclohexyl]-5-(4-Phenoxyphenyl)-7h-Pyrrolo[2,3-D]pyrimidin-4-Amine | IC50 | 0.3 [1], 59.0 [2], 2030.0 [3] |
 | Dasatinib | IC50 | 0.2 [1], 0.5 [2] |
 | Ibrutinib | IC50 | 95.6 [1] |
 | 1-(Tert-Butyl)-3-(p-tolyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 10.0 [1], 27.0 [2] |
 | PDGF Receptor Tyrosine Kinase Inhibitor IV | IC50 | 378.0 [1] |
 | 1-(Tert-Butyl)-3-(naphthalen-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 600.0 [1] |
 | 1-[4-Amino-7-(3-hydroxypropyl)-5-(4-methylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-2-fluoroethanone | IC50 | 1.0 [1], 4000000.0 [2] |
 | N-(2-Chloro-6-methylphenyl)-2-[(2,6-dimethylpyrimidin-4-yl)amino]-1,3-thiazole-5-carboxamide | IC50 | 1.0 [1] |
 | 1-(4-Amino-7-(3-hydroxypropyl)-5-(p-tolyl)-7h-pyrrolo[2,3-d]pyrimidin-6-yl)-2-chloroethanone | IC50 | 100.0 [1], 4000000.0 [2] |
 | N-[4-[4-Amino-7-[(E)-3-[(4-aminocyclohexyl)amino]prop-1-enyl]thieno[3,2-c]pyridin-3-yl]-2-methoxyphenyl]-1-methylindole-2-carboxamide | IC50 | 25900.0 [1], 26300.0 [2] |
 | 1-(2,2-Diethoxyethyl)-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 1226.0 [1], 1230.0 [2] |
 | 2-PropenaMide, N-[cis-4-[4-aMino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyriMidin-1-yl]cyclohexyl]- | IC50 | 7.1 [1] |
 | Dopamine | IC50 | 100000.0 [1] |
 | Genistein | IC50 | 58180.0 [1] |
 | Crizotinib | IC50 | 10000.0 [1] |
 | Harmine | IC50 | 250000.0 [1] |
 | 1-Tert-butyl-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 10.0 [1] |
 | Palbociclib | IC50 | 10000.0 [1] |
 | Su6656 | IC50 | 170.0 [1] |
 | Sotrastaurin | IC50 | 5500.0 [1] |
 | 1H-Inden-2-amine, 2,3-dihydro-5,6-dimethoxy-N,N-dipropyl- | IC50 | 100000.0 [1] |
 | Lfm-a13 | IC50 | 240000.0 [1] |
 | Pyridone 6 | IC50 | 500.0 [1] |
 | (5e)-5-(Quinolin-6-Ylmethylidene)-2-[(Thiophen-2-Ylmethyl)amino]-1,3-Thiazol-4(5h)-One | Ki | 2000.0 [1] |
 | (5Z)-5-(Quinolin-6-ylmethylidene)-2-[(thiophen-2-ylmethyl)amino]-1,3-thiazol-4(5H)-one | Ki | 2000.0 [1] |
 | 4-[2-(Dipropylamino)ethyl]benzene-1,2-diol | IC50 | 100000.0 [1] |
 | Raf265(chir-265) | IC50 | 10000.0 [1] |
 | (3Z)-3-[(2,4,6-Trimethoxyphenyl)methylidene]-1H-indol-2-one | IC50 | 100000.0 [1] |
 | 4-Amino-5-(4-Phenoxyphenyl)-7h-Pyrrolo[2,3-D]pyrimidin-7-Yl-Cyclopentane | IC50 | 126.0 [1] |
 | 1-Tert-butyl-3-(naphthalen-1-ylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 1000.0 [1] |
 | LY-3009120 | IC50 | 91.0 [1] |
 | 3-((4-Bromo-2,6-difluorobenzyl)oxy)-5-(3-(4-(pyrrolidin-1-yl)butyl)ureido)isothiazole-4-carboxamide | IC50 | 161.0 [1] |
 | CID 6918852 | Ki | 5000.0 [1] |
 | A-770041 | IC50 | 44100.0 [1] |
 | CID 44219749 | IC50 | 50000.0 [1] |
 | JNK Inhibitor VIII | Ki | 810.0 [1] |
 | 6-(Dipropylamino)-5,6,7,8-tetrahydronaphthalene-2,3-diol | IC50 | 50000.0 [1] |
 | Bms-509744 | IC50 | 1100.0 [1] |
 | Ilorasertib | IC50 | 110.0 [1] |
 | CID 56649281 | IC50 | 11.09 [1] |
 | N-Benzyl-1-(2-chloro-2-phenylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | Ki | 3500.0 [1] |
 | 4-[(2,4-Dichlorophenyl)amino]-6,7-dimethoxy-3-quinolinecarbonitrile | IC50 | 10000.0 [1] |
 | CID 44814409 | IC50 | 10000.0 [1] |
 | Unii-mbe6kwv0QI | Ki | 100.0 [1] |
 | 7-(2,6-Dimethylphenyl)-5-methyl-N-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-1,2,4-benzotriazin-3-amine | IC50 | 23.0 [1] |
 | 4-[2-(3-Tert-butylanilino)-1-methylbenzimidazol-5-yl]oxy-N-methylpyridine-2-carboxamide | IC50 | 5.0 [1] |
 | N-Acetyl-O-phosphono-Tyr-Glu-Glu-Ile-Glu | IC50 | 1100.0 [1] |
 | 1-(2-Chloro-2-phenylethyl)-6-(2-morpholin-4-ylethylsulfanyl)-N-phenylpyrazolo[3,4-d]pyrimidin-4-amine | Ki | 7500.0 [1] |
 | (2R)-2-[(2S)-4-[3-Chloro-5-fluoro-6-(2H-pyrazolo[3,4-b]pyridin-3-yl)pyridin-2-yl]piperazin-2-yl]-3-methylbutan-2-ol | Ki | 1000.0 [1] |
 | Unii-8FX9DP2Y1W | IC50 | 5.0 [1] |
 | N-(2-Chloro-6-methylphenyl)-2-[(cyclopropylcarbonyl)amino]-1,3-thiazole-5-carboxamide | IC50 | 71.0 [1] |
 | N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)acetamide | Ki | 810.0 [1] |
 | 4-Amino-5-chloro-6-ethoxy-pyridine-2-carboxylic acid 4-methanesulfonyl-benzylamide | IC50 | 810.0 [1] |
 | 1-(2,6-Dichlorophenyl)-5-(2,4-difluorophenyl)-7-(4-piperidinyl)-1,2,3,4-tetrahydroquinazoline-2-one | IC50 | 10000.0 [1] |
 | (3Z)-N-Methyl-3-[[3-[3-(4-methylpiperazin-1-yl)propyl]-4,5,6,7-tetrahydro-1H-indol-2-yl]methylidene]-2-oxo-1H-indole-5-sulfonamide | IC50 | 800.0 [1] |
 | 7-Chloro-3-oxo-8-(1,3-thiazol-5-ylmethylamino)-11,16-dioxa-2,4,19,21-tetrazatricyclo[15.3.1.05,10]henicosa-1(20),5,7,9,17(21),18-hexaene-18-carbonitrile | Ki | 809.0 [1] |
 | 1-({4-[(3,4-Dichlorophenyl)methoxy]phenyl}methyl)azetidine-3-carboxylic acid | IC50 | 10000.0 [1] |
 | 1-(2-Chloro-2-phenyl-ethyl)-6-(2-morpholinoethylsulfanyl)-N-propyl-pyrazolo[3,4-d]pyrimidin-4-amine | Ki | 8150.0 [1] |
 | 1-(2-Chloro-2-phenylethyl)-N-[(4-fluorophenyl)methyl]-6-(2-morpholin-4-ylethylsulfanyl)pyrazolo[3,4-d]pyrimidin-4-amine | Ki | 15500.0 [1] |
 | 4-Phenylamino-3-quinolinecarbonitrile deriv. 25 | IC50 | 3200.0 [1] |
 | 7-Chloro-8-(3-hydroxypropoxy)-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaene-19-carbonitrile | Ki | 10000.0 [1] |
 | 7-Chloro-8-(3-hydroxypropyl)-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5(10),6,8,18(22),19-hexaene-19-carbonitrile | Ki | 10000.0 [1] |
 | N-(7-Chloro-19-cyano-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaen-8-yl)methanesulfonamide | Ki | 10000.0 [1] |
 | N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)-2-(2,5-dimethoxy-4-methylsulfonylphenyl)acetamide | Ki | 810.0 [1] |
 | cis-3-(3-Azetidin-1-ylmethylcyclobutyl)-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-8-ylamine | IC50 | 10000.0 [1] |
 | 1-[4-(3-Amino-1-methylpyrazolo[3,4-c]pyridin-4-yl)phenyl]-3-(3-methylphenyl)urea | IC50 | 12500.0 [1] |
 | 3-[5-[3-(2-Methoxyethoxy)prop-1-ynyl]thiophen-3-yl]-7-(1,2,4-triazol-1-ylmethyl)-1,4-dihydroindeno[1,2-c]pyrazole | IC50 | 50000.0 [1] |
 | N-(4-Amino-5-chloro-6-ethoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 810.0 [1] |
 | N-(4-Amino-5-cyano-6-isopropoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 810.0 [1] |
 | N-(4-Amino-5-cyano-6-phenylpyridin-2-yl)acetamide | Ki | 810.0 [1] |
 | Tert-butyl N-[4-[4-amino-1-[2-[4-(dimethylamino)piperidin-1-yl]ethyl]pyrazolo[3,4-d]pyrimidin-3-yl]-2-methoxyphenyl]carbamate | IC50 | 2.1 [1] |
 | 2-(Dipropylamino)-2,3-dihydro-1H-inden-5-ol | IC50 | 100000.0 [1] |
 | 2-[[N-[2-[3-Ethylsulfonyl-4-(4-methylpiperazin-1-yl)anilino]-5-fluoropyrimidin-4-yl]-5-(hydroxymethyl)-2-methylanilino]methyl]benzonitrile | IC50 | 45.0 [1] |
 | Ripk1-IN-7 | IC50 | 187.0 [1] |
 | 3-{[(1R)-1-Phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione | IC50 | 50000.0 [1] |
 | N-(2-Chloro-6-fluorobenzyl)-5-(furan-2-yl)-2H-1,2,4-triazol-3-amine | IC50 | 600.0 [1] |
 | N-Propyl-4-({4-[(2,2,2-trifluoroethyl)amino]-1H-pyrrolo[2,3-d]pyrimidin-2-yl}amino)benzamide | IC50 | 1030.0 [1] |
 | 6-[(4-Methylpiperazin-1-yl)methyl]-3-[5-(3-phenoxyprop-1-ynyl)thiophen-3-yl]-1,4-dihydroindeno[1,2-c]pyrazole | IC50 | 27300.0 [1] |
 | 2-Methoxy-12-(2-hydroxyethyl)-13,14-dihydronaphthol[2,1-a]pyrrolo[3,4-c]carbazole-5-one | IC50 | 3400.0 [1] |
 | [6-Chloro-4-methyl-3-[[3-(methylsulfamoylamino)phenyl]methyl]-2-oxochromen-7-yl] N,N-dimethylcarbamate | IC50 | 50000.0 [1] |
 | N-(3-(2-(Pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl)phenyl)-3-(trifluoromethyl)benzamide | IC50 | 50000.0 [1] |
 | CID 25207521 | IC50 | 50000.0 [1] |
 | 7-Fluoro-1-methyl-9H-pyrido[3,4-b]indole | IC50 | 250000.0 [1] |
 | 1-(5-Methyl-1H-imidazol-4-yl)-9H-beta-carboline | IC50 | 250000.0 [1] |
Calculator
